Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor
1
x
$
30.00
VOL 2 No. 3 Full Issue - March 2000
1
x
$
20.00
Philip T. Ninan, MD: New Insights Into the Diagnosis and Pharmacologic Management of Generalized Anxiety Disorder
1
x
$
30.00
Efficacy of Omega-3 Fatty Acids in Mood Disorders
1
x
$
30.00
A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms
1
x
$
30.00
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) for Treatment of Fibromyalgia: A Comprehensive Clinical Review
1
x
$
30.00
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
1
x
$
30.00
Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains
1
x
$
30.00
Assessment of Anxiety in Clinical Trials with Depressed Patients
1
x
$
30.00
New Developments in the Neurobiological Basis of Anxiety Disorders
1
x
$
30.00
Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?
1
x
$
30.00
Clozapine Factors in Schizophrenia by Takefumi Suzuki
1
x
$
30.00
View Cart
Checkout
Home
but-is-it-sufficient
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
$
30.00
Add to cart
Details
Page load link
Go to Top
